Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Blood metabolomics, smoking and lung cancer risk

Principal Investigator
Name
Wei Jie Seow
Degrees
Sc.D.
Institution
National University of Singapore
Position Title
Assistant Professor
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-558
Initial CDAS Request Approval
Dec 16, 2019
Title
Blood metabolomics, smoking and lung cancer risk
Summary
Lung cancer is the leading cause of cancer mortality that accounted for 1.6 million deaths worldwide. Metabolomics is the rapid, high-throughput detection and quantification of small-molecules such as metabolite intermediates, food components and hormones found in an organism. The relationships of these metabolites with lung cancer risk are still largely unknown. Therefore, we propose to identify the associations between metabolite levels and lung cancer risk in the PLCO that measured pre-diagnostic blood metabolite levels. We also propose to assess the association between smoking and blood metabolites.
Aims

Aim 1: To examine the association between pre-diagnostic blood metabolite levels and lung cancer risk in the PLCO.
Aim 2: To identify metabolites that are associated with smoking.

Collaborators

Dr. Steve Moore, Dr. Nathan Appel

Related Publications